Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHELLE M MYERS

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1962911032
CMS profile
11226687
Location
AKRON, OH

General Payments · PY2021–2023

$885.99

  • Reported across 33 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$411.38

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $411.38 16

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $344.60 10
PY2022 $130.01 7
PY2023 $411.38 16

Payment records · PY2023 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.08 01/23/2023 Food and Beverage Undisputed 01/23/2026 1018095663 CMS
Abbott Laboratories $21.22 10/09/2023 Food and Beverage Undisputed 01/23/2026 1018098401 CMS
AstraZeneca Pharmaceuticals LP $14.93 02/10/2023 Food and Beverage Undisputed 01/23/2026 1014924161 CMS
AstraZeneca Pharmaceuticals LP $18.84 04/06/2023 Food and Beverage Undisputed 01/23/2026 1012041661 CMS
AstraZeneca Pharmaceuticals LP $17.65 04/28/2023 Food and Beverage Undisputed 01/23/2026 1011688359 CMS
AstraZeneca Pharmaceuticals LP $10.92 06/29/2023 Food and Beverage Undisputed 01/23/2026 1015246303 CMS
AstraZeneca Pharmaceuticals LP $124.87 11/02/2023 Food and Beverage Undisputed 01/23/2026 1015732573 CMS
CVRx, Inc. $19.19 02/28/2023 Food and Beverage Undisputed 01/23/2026 1057764069 CMS
Daiichi Sankyo Inc. $18.51 10/24/2023 Food and Beverage Undisputed 01/23/2026 1006515991 CMS
E.R. Squibb & Sons, L.L.C. $18.41 03/07/2023 Food and Beverage Undisputed 01/23/2026 1016064383 CMS
E.R. Squibb & Sons, L.L.C. $19.62 05/09/2023 Food and Beverage Undisputed 01/23/2026 1016064405 CMS
Novartis Pharmaceuticals Corporation $17.43 05/25/2023 Food and Beverage Undisputed 01/23/2026 992810007 CMS
Novartis Pharmaceuticals Corporation $30.56 11/21/2023 Food and Beverage Undisputed 01/23/2026 992810043 CMS
SCPHARMACEUTICALS INC. $19.98 12/04/2023 Food and Beverage Undisputed 01/23/2026 995504641 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $21.26 05/02/2023 Food and Beverage Undisputed 01/23/2026 984014489 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $17.91 09/11/2023 Food and Beverage Undisputed 01/23/2026 984014485 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.